Proteinuria (protein in urine) is common with complement 3 glomeropathy and is a strong predictor of disease progression and end-stage kidney failure.
Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using ...
U.S. commercial launch in thalassemia underway following December 2025 FDA approvalPre-sNDA meeting with FDA for mitapivat ...
Yield-Enhanced Production Execution. Yield-enhanced production moved into routine commercial execution during 2025, with ...